Gold and silver flower mountain silver flower dispute results The Food and Drug Administration asked pharmaceutical companies to change the prescription name

, the State Administration of Food and Drug Administration (FDA) published on its official website "Reply Letter on issues related to the sub-divisional management of Chinese herbal medicine varieties
(
referred to as "Reply letter
"
. "Reply letter" pointed out that the production enterprises will be prescribed gold and silver flowers clearly for mountain silver flowers, should be changed to mountain silver flowers material production, and according to the requirements for the record.this, the General Administration of Food and Drug Administration will be the southern gold and silver flower renamed mountain silver flower has become a fact, after the boiling gold and silver flower, mountain silver flower controversy seems to settle the dust.Challenger: Favorable Mountain Silver Flower Re-enters the Market In
August
this year, Lu Qun
, Deputy Director of the Corruption Prevention Office of the Hunan Provincial Commission for Discipline Inspection, published a group of


Weibo, which is the "right name for the southern gold and silver flowers", said that the
2005 edition of the
Chinese Pharmacopoeia changed the southern gold and silver flowers into mountain silver flowers, resulting in the gold and silver flowers becoming the special name of Shandong Yindong, causing huge economic losses to the southern gold and silver flower farmers.he also pointed out that the gold and silver flowers, mountain silver flowers behind the controversy involved in a huge dispute of interests. Subsequently, the State Pharmacopeia Commission, the General Administration of Food and Drug Administration has responded, saying that gold and silver flowers and mountain silver flowers in plant shape, medicinal properties and chemical composition, there are differences, will be "gold and silver flowers and mountain silver flowers in the pharmacopeia listed, conducive to drug safety."yesterday, Lu Qun on the General Administration of Food and Drug Administration's "reply letter" in the circle of friends wrote:Although the major corrective measures, but has not been completely for the 'mountain silver flower' name."Last night, Lu Qun told the Beijing News reporter that after the southern gold and silver flowers were renamed, the original drug and food as raw materials can not be used legally, must be the prescription of "gold and silver flowers" to mountain silver flowers, but the Pharmacopeia Commission in the approval of the harsh conditions, time is limited to almost no operating space. Now the General Administration of Food and Drug Administration has withdrawn the right to file from the Pharmacopeia Commission, lifting the time limit and lowering the threshold for approval. This is good news for the mountain silver flower to re-enter the food and drug market.he still believes that the southern gold and silver flower is completely unnecessary and the reason to change to mountain silver flower, "if not corrected, I will continue to pay attention to and attack." " changed its name to
29,
pharmaceutical companies
15,
varieties "Reply letter" pointed out that the original dosage form has been prescribed gold and silver flowers clearly as mountain silver flowers, but related In order to avoid creating a new problem of "heteronorcing the same name", enterprises shall change the prescription gold and silver flowers to the production of mountain silver flowers, and shall, as required, file instructions and labels with the provincial Food and Drug Administration in the locality.the contents of the items related to identification, examination and content determination in the drug standards, the corresponding applications shall be made in accordance with the procedures for revising the national drug standards or the drug registration standards.reporter yesterday called Jiangxi Yintao Pharmaceuticals and Jinling Pharmaceuticals related to the person in charge, the other side said that they are aware of this "reply letter", but the changes involving modified varieties have not been completed. The formulation description of the relevant modified varieties on the official websites of the two pharmaceutical companies is still gold and silver flowers.it is understood that the above-mentioned reply is involved in Jinling Pharmaceuticals, Jiangxi Yintao Pharmaceuticals, Jilin Jichun Pharmaceuticals and other
29,
pharmaceutical enterprises
15,
modified varieties.